“…(Raghuram et al, 2007;Yin et al, 2007) A synthetic agonist, GSK4112, has been described (Grant et al, 2010) Rev-erbb NR1D2 EAR1b, RVR, BD73 ENSG00000174738 Haem (Raghuram et al, 2007;Yin et al, 2007) A synthetic agonist, GSK4112, has been described (Grant et al, 2010) (Young et al, 1998); gene disruption appears without effect on testicular development or function (Shyr et al, 2002)) TLX NR2E1 Tailless homolog, TLL ENSG00000112333 Gene disruption is associated with abnormal brain development (Monaghan et al, 1997;Land and Monaghan, 2003) PNR NR2E3 Photoreceptor-specific nuclear receptor, retina-specific nuclear receptor ENSG00000031544 -COUP-TFI NR2F1 COUPa, EAR3, SVP44 ENSG00000175745 Gene disruption is perinatally lethal (Qiu et al, 1997) COUP-TFII NR2F2 COUPb, ARP1, SVP40 ENSG00000185551 Gene disruption is embryonically lethal (Pereira et al, 1999) EAR2 NR2F6 V-erb-related gene ENSG00000160113 Gene disruption impairs CNS development (Warnecke et al, 2005) (Suetsugi et al, 2003); activated by the synthetic agonist GSK4716 (Zuercher et al, 2005) and blocked by XCT790 (Willy et al, 2004) ERRb NR3B2 ESRL2, estrogen-related receptor b, estrogen receptor-like 2…”